It was also shown that 1, at a concentration of 5 μM, exhibits antiandrogenic activity in human prostate cancer cell lines (e.g., LNCaP), preventing the binding of labeled synthetic androgen R1881 (5 nM) to the androgen receptor (AR). The gene discussed is AR; the disease is prostate cancer.